ArticleLancet regional health. Americas2023

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States.

Ayodeji Adegunsoye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.